Ultragenyx Pharmaceutical

^{Priced, Nasdaq: RARE}

Clinical-stage biotech developing treatments for rare metabolic genetic diseases.

Industry: Health Care

First Day Return: +101.2%

RARE

Clinical-stage biotech developing treatments for rare metabolic genetic diseases.

IPO News for Ultragenyx Pharmaceutical

Renaissance IPO Index - Notice of September 2015 Quarterly Changes 09/11/15
US IPO Recap: Varonis provides data security for enterprises and financial security for investors 03/03/14
US IPO Recap: Ultragenyx doubles and Dicerna triples in home-run week for biotech IPOs 02/03/14

IPO Data
IPO Date	01/30/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$121
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.ultragenyx.com
Headquarters	Novato, CA, United States
Founded	2010
Employees at IPO	59

IPO News for Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical (RARE) Performance